IBRX → $14.00 by Apr 29, 2026.

Unsloppy AI slop: Current market data for ImmunityBio (IBRX) as of January 28, 2026, indicates a highly "crowded" short trade. The setup suggests that shorts are currently paying high premiums to hold their positions, and the "days to cover" metric is high enough that any significant price jump could trigger a panic. Here is the evaluation of the data and the specific price levels that would likely trigger a short squeeze. 1. Current Short Data Snapshot * Short Interest (SI) …